Elegaiter uses gait to support a life insurer's healthcare CRM and early chronic-disease risk detection — at the same time.
Linking Elegaiter's real-time gait data into an insurer's own digital content lets the insurer's brand character appear directly as the user's interaction partner inside the content. For example, the character can act as a pacer or coach that runs alongside the user in real time, matching the user's actual walking speed and rhythm. Users then interact with this character every time they exercise — turning a daily habit into a recurring, non-intrusive CRM touchpoint with the brand.
With no camera or wearable to put on — just the treadmill already in place — this captures data quantified down to left-right balance and gait stability, not just step counts. It can drive higher exercise engagement and connect directly to incentive programs such as points or rewards for reaching activity goals.
Elegaiter continuously measures the user's gait data throughout this process. When patterns diverge from the norm — reduced activity, worsening left-right imbalance — that signal can be passed to the insurer's own healthcare risk-management system, for their team to use directly in deciding when to intervene and in proposing a tailored management program.
JAWS Adapter
Measures treadmill instantaneous current
Real-Time Gait Data
Walk/run · left-right balance · gait stability
Brand Character Appears
Pacer/coach interaction · CRM · incentives
Insurer Risk Management
Early detection of abnormal patterns · intervention signal
How walking helps — risk reduction evidence for the chronic conditions that drive life-insurance loss ratios
Large-scale studies link consistent walking to lower risk across the chronic conditions that drive life-insurance loss ratios.
Let's work out the potential impact together
Share your claims volume and policyholder profile, and we'll help estimate the potential loss-ratio improvement for your business based on the research above. Since there is no deployed case yet, we're looking for the first partner to build that evidence together with us.
This is a scenario under review, not a deployed case. The research cited concerns walking as an activity in general, not a clinical claim about the Elegaiter product itself. Elegaiter is not a medical device and is not intended to diagnose, treat, cure, or prevent any disease.